Photo: Clinical trial participant Tom Giarratana with daughter Lily
For patients with advanced or metastatic chordoma, clinical trials can be a lifeline. But for many, the cost of traveling to participate in these trials can put that hope out of reach.
We believe every eligible chordoma patient deserves the chance to participate in a promising clinical trial, no matter where they live — and that by helping them do so, we can accelerate trial completion for the benefit of countless other patients.
That’s where our Clinical Trial Assistance Program comes in.
Already, the program — which provides financial support to eligible patients who need to travel to participate in a clinical trial — has made a profound difference: 21 of the 25 patients in the ongoing cetuximab clinical trial were only able to participate because of financial support from our donors.
And thanks to the accelerated pace of research at Chordoma Foundation Labs, we're seeing a growing pipeline of new therapies poised to enter clinical trials. Each represents new hope for patients facing limited treatment options. But it also means more families will need our support to access these promising treatments.
Your gift today will help ensure that no patient has to decline a potentially life-prolonging treatment opportunity due to travel costs:
By enabling more patients to access new clinical trials, you're directly helping people affected by chordoma have a chance at more precious days, months, and years with their loved ones.
And you're increasing the likelihood that these trials will succeed and go on to benefit patients everywhere.
We deeply appreciate your partnership!
Testimonial